Growth Metrics

PAVmed (PAVM) Equity Income (2024 - 2025)

PAVmed has reported Equity Income over the past 2 years, most recently at $2.5 million for Q4 2025.

  • For Q4 2025, Equity Income rose 1903.2% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $8.5 million, changed N/A, while the annual FY2025 figure was $8.5 million, 1494.55% up from the prior year.
  • Equity Income for Q4 2025 was $2.5 million at PAVmed, up from -$4.4 million in the prior quarter.
  • Over five years, Equity Income peaked at $21.0 million in Q1 2025 and troughed at -$10.6 million in Q2 2025.